Soledad im soledad obrien. Welcome to matter of fact. How will the covid 19 pandemic end . The most certain way would be the development of a safe and effective vaccine. Private companies and governments worldwide are racing to produce a vaccine by the end of the year. But doctor anthony fauci, the countrys top Infectious Disease expert said it could take 12 to 18 months. And even that timeline would be ambitious by historical standards. There are roughly 100 candidates for a vaccine in the works, with a handful fasttracked for human trials. The Clinical Development of a Vaccine Development has three phases. First, its given to a small group of people, then a bigger group, then an even bigger group, in order to test if its safe and effective. And these series of tests can take years, which has led to calls for a different type of testing. Our special contributor joie chen looks at the push for human challenge trials. Josh my names Josh Morrison. Im a volunteer for human challenge trial
During the hearing nih director and other leaders from the agency field questions on Psychedelic Drug research and maternal care among other topics. This is just over one hour 45 minutes. The Senate Appropriations subcommittee on labor, health, and human services, education and related agencies will please come to order. Good morning. Today is our fourth hearing on the biden administrations fiscal year 2025 budget request, and im happy to welcome dr. Bertinoli to testify for the first time in this committee as the director for the National Institutes for health. As the granddaughter of a n. I. H. Funded doctor myself, i understand the Important Role Biomedical Research plays in treating and curing disease and bolstering our Economic Growth and ensuring america is a Global Leader in innovation. I know my colleagues here today agree. Im looking forward to working in a bipartisan manner again this year to develop a labor h. H. S. Bill that can pass the senate, pass the house, and be signe
Completely unfiltered. Cspan, your unfiltered view of government. Up next, a Senate Appropriations subcommittee hears testimony on the National Institutes of health 2025 budget request. During the hearing, n. I. H. Director dr. Monica bertinoli and others field questions on fentanyl overdoses and maternal care with other topics. This is an hour and 45 minutes. The Senate Appropriations subcommittee on labor, health, and human services, education and related agencies will please come to order. Good morning. Today is our fourth hearing on the biden administrations fiscal year 2025 budget request, and im happy to welcome dr. Bertinoli to testify for the first time in this committee as the director for the National Institutes for health. As the granddaughter of a n. I. H. Funded doctor myself, i understand the Important Role Biomedical Research plays in treating and curing disease and bolstering our Economic Growth and ensuring america is a Global Leader in innovation. I know my colleagues
That would be helpful. This might be you name it. And i suspect you will get an honorary phd here pretty soon in neuroscience. But when it was first set up we asked the group of experts to sit down with us and to give us the best idea of how to develop this and they created this it would grow to roughly 500 million per year and we will hopefully be a part of this. So we will be about 80 million with the president s request next year of another 70 million that will take us up seeing how spectacular scientific opportunities are, people say in the great roadmap is there any gas in the car. People really concerned and we are hoping that we can do other projects and we would like to have another 50 or so come out but after that whether we could build this and the way in which we had originally envisioned. Thank you mr. Chairman. There are americans counting on your work in this regard. The gentlemans gracious complement. Next we will go to my good friend. Thank you, mr. Chairman, to all of
16. Im happy to. Nkats, now just three years old, was the first new center at nih again, quite a long time and was focused in trying to identify the bottle necks from going from basic science discoveries to benefits. In collaboration with our partners in the private sector. I think initially there were some concerns that nih is becoming a drug company, that really was never the plan and is not happening now. Instead, we are identifying areas of Technology Development that no Single Company could undertake, but working with them, we can give you just one example. The effort to try to figure out when youre developing a new drug, whether its going to be safe in humans or not. Has been a real difficult one. We use animal studies, small animals, large animals. Its not that accurate. Its slow, its expensive. We probably lose drugs along the way because some mouse got a slight liver issue and it probably would have had no relevance to humans but we sort of lose the drug at that point. Wouldnt